Disruption of FOXO3a-miRNA feedback inhibition of IGF2/IGF-1R/IRS1 signaling confers Herceptin resistance in HER2-positive breast cancer

Resistance to Herceptin represents a major challenge for successful treatment of HER2-positive breast cancer. Here, the authors demonstrate that the activation of the IGF2/IRS1 signal caused by disruption of a negative feedback loop between FOXO3a-miR-128/miR-30/miR-193 induces Herceptin resistance.

Guardado en:
Detalles Bibliográficos
Autores principales: Liyun Luo, Zhijie Zhang, Ni Qiu, Li Ling, Xiaoting Jia, Ying Song, Hongsheng Li, Jiansheng Li, Hui Lyu, Hao Liu, Zhimin He, Bolin Liu, Guopei Zheng
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/c2ab2374f4c049a490b02ad183f4c03c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c2ab2374f4c049a490b02ad183f4c03c
record_format dspace
spelling oai:doaj.org-article:c2ab2374f4c049a490b02ad183f4c03c2021-12-02T15:36:11ZDisruption of FOXO3a-miRNA feedback inhibition of IGF2/IGF-1R/IRS1 signaling confers Herceptin resistance in HER2-positive breast cancer10.1038/s41467-021-23052-92041-1723https://doaj.org/article/c2ab2374f4c049a490b02ad183f4c03c2021-05-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-23052-9https://doaj.org/toc/2041-1723Resistance to Herceptin represents a major challenge for successful treatment of HER2-positive breast cancer. Here, the authors demonstrate that the activation of the IGF2/IRS1 signal caused by disruption of a negative feedback loop between FOXO3a-miR-128/miR-30/miR-193 induces Herceptin resistance.Liyun LuoZhijie ZhangNi QiuLi LingXiaoting JiaYing SongHongsheng LiJiansheng LiHui LyuHao LiuZhimin HeBolin LiuGuopei ZhengNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-16 (2021)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Liyun Luo
Zhijie Zhang
Ni Qiu
Li Ling
Xiaoting Jia
Ying Song
Hongsheng Li
Jiansheng Li
Hui Lyu
Hao Liu
Zhimin He
Bolin Liu
Guopei Zheng
Disruption of FOXO3a-miRNA feedback inhibition of IGF2/IGF-1R/IRS1 signaling confers Herceptin resistance in HER2-positive breast cancer
description Resistance to Herceptin represents a major challenge for successful treatment of HER2-positive breast cancer. Here, the authors demonstrate that the activation of the IGF2/IRS1 signal caused by disruption of a negative feedback loop between FOXO3a-miR-128/miR-30/miR-193 induces Herceptin resistance.
format article
author Liyun Luo
Zhijie Zhang
Ni Qiu
Li Ling
Xiaoting Jia
Ying Song
Hongsheng Li
Jiansheng Li
Hui Lyu
Hao Liu
Zhimin He
Bolin Liu
Guopei Zheng
author_facet Liyun Luo
Zhijie Zhang
Ni Qiu
Li Ling
Xiaoting Jia
Ying Song
Hongsheng Li
Jiansheng Li
Hui Lyu
Hao Liu
Zhimin He
Bolin Liu
Guopei Zheng
author_sort Liyun Luo
title Disruption of FOXO3a-miRNA feedback inhibition of IGF2/IGF-1R/IRS1 signaling confers Herceptin resistance in HER2-positive breast cancer
title_short Disruption of FOXO3a-miRNA feedback inhibition of IGF2/IGF-1R/IRS1 signaling confers Herceptin resistance in HER2-positive breast cancer
title_full Disruption of FOXO3a-miRNA feedback inhibition of IGF2/IGF-1R/IRS1 signaling confers Herceptin resistance in HER2-positive breast cancer
title_fullStr Disruption of FOXO3a-miRNA feedback inhibition of IGF2/IGF-1R/IRS1 signaling confers Herceptin resistance in HER2-positive breast cancer
title_full_unstemmed Disruption of FOXO3a-miRNA feedback inhibition of IGF2/IGF-1R/IRS1 signaling confers Herceptin resistance in HER2-positive breast cancer
title_sort disruption of foxo3a-mirna feedback inhibition of igf2/igf-1r/irs1 signaling confers herceptin resistance in her2-positive breast cancer
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/c2ab2374f4c049a490b02ad183f4c03c
work_keys_str_mv AT liyunluo disruptionoffoxo3amirnafeedbackinhibitionofigf2igf1rirs1signalingconfersherceptinresistanceinher2positivebreastcancer
AT zhijiezhang disruptionoffoxo3amirnafeedbackinhibitionofigf2igf1rirs1signalingconfersherceptinresistanceinher2positivebreastcancer
AT niqiu disruptionoffoxo3amirnafeedbackinhibitionofigf2igf1rirs1signalingconfersherceptinresistanceinher2positivebreastcancer
AT liling disruptionoffoxo3amirnafeedbackinhibitionofigf2igf1rirs1signalingconfersherceptinresistanceinher2positivebreastcancer
AT xiaotingjia disruptionoffoxo3amirnafeedbackinhibitionofigf2igf1rirs1signalingconfersherceptinresistanceinher2positivebreastcancer
AT yingsong disruptionoffoxo3amirnafeedbackinhibitionofigf2igf1rirs1signalingconfersherceptinresistanceinher2positivebreastcancer
AT hongshengli disruptionoffoxo3amirnafeedbackinhibitionofigf2igf1rirs1signalingconfersherceptinresistanceinher2positivebreastcancer
AT jianshengli disruptionoffoxo3amirnafeedbackinhibitionofigf2igf1rirs1signalingconfersherceptinresistanceinher2positivebreastcancer
AT huilyu disruptionoffoxo3amirnafeedbackinhibitionofigf2igf1rirs1signalingconfersherceptinresistanceinher2positivebreastcancer
AT haoliu disruptionoffoxo3amirnafeedbackinhibitionofigf2igf1rirs1signalingconfersherceptinresistanceinher2positivebreastcancer
AT zhiminhe disruptionoffoxo3amirnafeedbackinhibitionofigf2igf1rirs1signalingconfersherceptinresistanceinher2positivebreastcancer
AT bolinliu disruptionoffoxo3amirnafeedbackinhibitionofigf2igf1rirs1signalingconfersherceptinresistanceinher2positivebreastcancer
AT guopeizheng disruptionoffoxo3amirnafeedbackinhibitionofigf2igf1rirs1signalingconfersherceptinresistanceinher2positivebreastcancer
_version_ 1718386379387305984